Top 10 Companies in the (2-Butyl-5-Nitro-3-Benzofuranyl)-(4-Hydroxyphenyl)-Methanone (CAS 141645-16-1) Market (2026–2034): Market Leaders Powering Global Pharmaceutical Intermediates

MARKET INSIGHTS

Global (2-Butyl-5-Nitro-3-Benzofuranyl)-(4-Hydroxyphenyl)-Methanone (CAS 141645-16-1) market size was valued at USD 3.2 million in 2025. The market is projected to grow from USD 3.5 million in 2026 to USD 5.8 million by 2034, exhibiting a CAGR of 6.5% during the forecast period.

(2-Butyl-5-Nitro-3-Benzofuranyl)-(4-Hydroxyphenyl)-Methanone (CAS 141645-16-1) is a specialized benzofuran-derived compound featuring a nitro-substituted benzofuranyl core coupled with a hydroxyphenyl ketone moiety. This compound is primarily utilized as a pharmaceutical intermediate and research chemical, playing a notable role in the synthesis of cardiovascular-active agents, including amiodarone-related analogs, owing to its structurally complex aromatic framework.

The market is witnessing steady growth driven by expanding pharmaceutical research activities and increasing demand for high-purity specialty intermediates in drug discovery pipelines. Growing investment in cardiovascular therapeutics and the rising prevalence of heart-related disorders globally are further reinforcing demand for this compound. Fine chemical manufacturers and contract research organizations (CROs) continue to expand their catalogs of niche benzofuran derivatives, contributing to broader market availability and accessibility for research and development applications worldwide.

(2-Butyl-5-Nitro-3-Benzofuranyl)-(4-Hydroxyphenyl)-Methanone (CAS 141645-16-1) Market – View in Detailed Research Report

Top 10 Companies in the (2-Butyl-5-Nitro-3-Benzofuranyl)-(4-Hydroxyphenyl)-Methanone (CAS 141645-16-1) Market (2026–2034)

🔟 1. Hairui Fine Chemicals Co., Ltd.

Headquarters: Shanghai, China
Key Offering: Pharmaceutical Grade Benzofuran Intermediates

Hairui Fine Chemicals specializes in the synthesis of high‑purity benzofuran derivatives for cardiovascular drug development. The company has recently scaled its biocatalytic processes, boosting yield by 20% while cutting solvent usage by 35%. Its expertise in nitro‑substituted benzofurans positions it as a preferred supplier for dronedarone and related analogs.

Sustainability & Growth Initiatives:

• Implementation of green chemistry protocols
• Waste‑to‑energy recovery systems
• Renewable energy sourcing for production lines

🔟 2. Shanghai Trustin Chemical Co., Ltd.

Headquarters: Shanghai, China
Key Offering: Research & Industrial Grade Benzofuranyl Compounds

Shanghai Trustin Chemical provides both research‑grade and industrial‑grade benzofuran intermediates with purity levels exceeding 99%. The firm’s advanced catalytic platforms enable rapid scale‑up for contract manufacturers, ensuring timely delivery for critical cardiovascular pipelines.

Sustainability & Growth Initiatives:

• Closed‑loop solvent recycling
• Carbon footprint reduction targets (30% by 2030)
• Partnerships with pharma giants for joint R&D

🔟 3. Finetech Industry Limited

Headquarters: Shenzhen, China
Key Offering: High‑Purity Pharmaceutical Intermediates

Finetech Industry focuses on delivering pharmaceutical‑grade intermediates for anti‑arrhythmic agents. Their proprietary synthesis route for nitro‑benzofurans offers superior stereochemical control, critical for dronedarone analog development.

Sustainability & Growth Initiatives:

• Energy‑efficient reactors
• Use of bio‑based solvents
• Continuous improvement programs for yield optimization

🔟 4. Clearsynth Labs Limited

Headquarters: Bengaluru, India
Key Offering: Custom Synthesis & Analytical Services

Clearsynth Labs provides bespoke synthesis of benzofuran derivatives for academic and industrial clients. Their compliance with US FDA and EU GMP standards makes them a trusted partner for high‑value cardiovascular research projects.

Sustainability & Growth Initiatives:

• Waste minimization through process intensification
• Adoption of renewable electricity
• Collaboration with Indian pharmaceutical clusters

🔟 5. Changzhou Weijia Chemical Co., Ltd.

Headquarters: Changzhou, China
Key Offering: Bulk Production of Benzofuran Intermediates

Changzhou Weijia offers large‑scale production of benzofuran intermediates, serving both domestic and export markets. Their high‑throughput synthesis platforms support the growing demand for cardiovascular intermediates.

Sustainability & Growth Initiatives:

• Water recycling systems
• Eco‑friendly packaging solutions
• Investment in R&D for greener processes

🔟 6. Toronto Research Chemicals Inc.

Headquarters: Toronto, Canada
Key Offering: Research‑Grade Benzofuranyl Compounds

Toronto Research Chemicals specializes in delivering research‑grade benzofuran derivatives to North American CROs and academic institutions, ensuring compliance with US and Canadian regulatory frameworks.

Sustainability & Growth Initiatives:

• Carbon neutrality roadmap
• Lean manufacturing practices
• Supplier sustainability assessment

🔟 7. Capot Chemical Co., Ltd.

Headquarters: Guangzhou, China
Key Offering: High‑Purity Intermediates for Cardiovascular Drugs

Capot Chemical delivers pharmaceutical‑grade benzofuran intermediates with stringent purity controls, supporting the development of novel anti‑arrhythmic agents.

Sustainability & Growth Initiatives:

• Energy‑saving manufacturing lines
• Green chemistry training programs
• Strategic alliances with global pharma firms

🔟 8. Pharmaffiliates Analytics & Synthetics

Headquarters: Hyderabad, India
Key Offering: Analytical & Synthetic Services for Benzofuranyl Compounds

Pharmaffiliates offers end‑to‑end synthesis and analytical support for benzofuran intermediates, facilitating rapid turnaround for R&D teams.

Sustainability & Growth Initiatives:

• Process optimization to reduce waste
• Use of green solvents
• Digital workflow integration

🔟 9. Chemtopex LLC

Headquarters: Los Angeles, USA
Key Offering: Custom Synthesis & Scale‑Up Services

Chemtopex provides custom synthesis of benzofuran intermediates for pharmaceutical companies, with a focus on rapid scale‑up and compliance with US GMP standards.

Sustainability & Growth Initiatives:

• Closed‑loop water recycling
• Renewable energy adoption
• Eco‑design of chemical processes

🔟 10. Ningbo Inno Pharmchem Co., Ltd.

Headquarters: Ningbo, China
Key Offering: Innovative Benzofuran Synthesis Platforms

Ningbo Inno Pharmchem develops cutting‑edge synthetic routes for nitro‑benzofurans, enhancing yield and purity for cardiovascular drug development.

Sustainability & Growth Initiatives:

• Energy efficiency upgrades
• Waste‑to‑resource programs
• Collaboration with research institutes

Download FREE Sample Report: https://www.24chemicalresearch.com/download-sample/307327/methanone-market

Get Full Report Here: https://www.24chemicalresearch.com/reports/307327/methanone-market

🌍 Outlook: The Future of (2-Butyl-5-Nitro-3-Benzofuranyl)-(4-Hydroxyphenyl)-Methanone (CAS 141645-16-1) Market

The market is expected to continue its upward trajectory as cardiovascular drug development accelerates and the demand for high‑purity intermediates grows. Emerging markets in Asia‑Pacific and Latin America are likely to capture a larger share, driven by expanding local pharmaceutical manufacturing and increasing investment in cardiovascular therapeutics. Regulatory harmonization and the adoption of green chemistry will further support market expansion.

📈 Key Trends Shaping the Market:

• Rising prevalence of atrial fibrillation fueling demand for anti‑arrhythmic intermediates.
• Shift toward safer oral alternatives and improved patient compliance.
• Expansion of generic and biosimilar production in regulated markets.
• Adoption of biocatalytic and green synthesis routes reducing environmental impact.
• Digital health integration for adherence monitoring and real‑world evidence generation.